Source link : https://www.newshealth.biz/health-news/adding-apalutamide-boosts-psa-control-in-prostate-cancer/
TOPLINE: A new study revealed that the addition of apalutamide to androgen deprivation therapy (ADT), with or without abiraterone acetate plus prednisone, prolongs prostate-specific antigen (PSA) progression-free survival in patients with biochemically recurrent prostate cancer. METHODOLOGY: Intensification of androgen blockade is known to improve survival in nonmetastatic castration-resistant prostate cancer as well as metastatic castration-sensitive […]
Author : News Health
Publish date : 2024-02-05 14:39:13
Copyright for syndicated content belongs to the linked Source.